Meet with… The Bill and Melinda Gates Foundation
Texas Medical Center , John P. McGovern Campus , Houston , TX 77021
December 01, 2015 from 11:30 AM to 13:30 PM (CDT)
$10 - $35
What does it take to save a life? The Bill & Melinda Gates Foundation Global Health Division aims to harness advances in science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools - including vaccines, drugs, and diagnostics - as well as discover path-breaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to those who need them most.
Charlotte Hubbert, Program Investment Officer at the Gates Foundation, will be in attendance to provide an overview presentation on the Foundation's key areas of interest and best practices when applying for funding. The Gates Foundation has made $3.6 billion in grant payments in 2013 with a total of $31.6 billion in grant payments since its inception.
Charlotte will be on hand to meet with a handful of applicants one-on-one.
10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and been approved. The application period ended on November 8th.
Bill & Melinda Gates Foundation Participating Representative:
Charlotte Hubbert | Program Investment Officer, Venture Investing, Bill & Melinda Gates Foundation
Charlotte Hubbert is a Program Investment Officer with the Bill & Melinda Gates Foundation focused on Venture Investing for innovative and technologies that support foundation initiatives in Global Health.
Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics and medical devices at all stages of development. Charlotte started her career in early stage biotech at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing and managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development and management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex. Charlotte currently serves as a member of the Scientific Advisory Board for Oncofactor Corporation.
Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14).
Connect with Charlotte:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until Nov 30th (or full).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ended on November 8th. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
Texas Medical Center
John P. McGovern Campus
2450 Holcombe Blvd, Suite X
Houston, TX 77021
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.